Skip to main content
OpenTrials

Clinical trial condition

Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (Stage IIIB-IV)

Explore clinical trials studying Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (Stage IIIB-IV). Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (Stage IIIB-IV) trial results

Completed

Immune-Modulated Study of Selected Small Molecules (Gefitinib, AZD9291, or Selumetinib + Docetaxel) or a 1st Immune-Mediated Therapy (IMT; Tremelimumab) With a Sequential Switch to a 2nd IMT (MEDI4736) in Patients With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer

NCT02179671

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Goodyear, Arizona, United States
  • Research Site Washington D.C., District of Columbia, United States
  • Research Site Augusta, Georgia, United States
  • Research Site Marietta, Georgia, United States
View Trial Details

Related conditions